Point-of-care β-hydroxybutyrate measurement predicts adequate glucose metabolism suppression in cardiac FDG-PET/CT.
Suvi HartikainenTuomo TompuriTiina LaitinenTomi LaitinenPublished in: Clinical physiology and functional imaging (2024)
BHB level measured with a point-of-care device is useful in predicting adequate myocardial glucose metabolism suppression. More detailed assessment of other factors potentially contributing to cardiac metabolism is needed.
Keyphrases